Search Results

Favourable effect of clavulanic acid on the minimum inhibitory concentrations of cefixime and ceftibuten in ESBL-producing Escherichia coli and Klebsiella pneumoniae.

• Authors : Martinez-Guerra BA; Department of Infectious Diseases, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico; Department of Infectious Diseases, Clinical Microbiology Laboratory, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico. Electronic address: .

Subjects: Klebsiella pneumoniae*/Klebsiella pneumoniae*/Klebsiella pneumoniae*/drug effects ; Klebsiella pneumoniae*/Klebsiella pneumoniae*/Klebsiella pneumoniae*/enzymology ; Escherichia coli*/Escherichia coli*/Escherichia coli*/drug effects

• Source: Journal of global antimicrobial resistance [J Glob Antimicrob Resist] 2024 Sep; Vol. 38, pp. 212-215. Date of Electronic Publication: 2024 Jun 28.Publisher: Published by Elsevier Ltd. on behalf of International Society of Chemotherapy for Infection and Cancer Country of Publication: Netherlands NLM ID:

Record details

A case study of impaired consciousness caused by alcohol consumption in a pediatric patient taking high-dose cefixime.

• Authors : Zheng L; Li G; Zhang L

Subjects: Cefixime*/Cefixime*/Cefixime*/adverse effects ; Cefixime*/Cefixime*/Cefixime*/administration & dosage ; Anti-Bacterial Agents*/Anti-Bacterial Agents*/Anti-Bacterial Agents*/adverse effects

• Source: International journal of clinical pharmacology and therapeutics [Int J Clin Pharmacol Ther] 2024 Sep; Vol. 62 (9), pp. 427-430.Publisher: Dustri-Verlag Dr. K. Feistle Country of Publication: Germany NLM ID: 9423309 Publication Model: Print Cited Medium: Print ISSN:

Record details

Degradation of cefixime by photocatalysis via Ba-doped BiFeO 3 nanomaterial using RSM analysis under LED light source.

• Authors : Ankita B; Department of Environmental Science, School of Life Sciences, JSS Academy of Higher Education & Research, S. S. Nagar, Mysuru, 570015, Karnataka, India.; Rakshitha R

Subjects: Nanostructures*/Nanostructures*/Nanostructures*/chemistry ; Water Pollutants, Chemical*/Water Pollutants, Chemical*/Water Pollutants, Chemical*/chemistry ; Water Pollutants, Chemical*/Water Pollutants, Chemical*/Water Pollutants, Chemical*/analysis

• Source: Environmental monitoring and assessment [Environ Monit Assess] 2024 Jun 17; Vol. 196 (7), pp. 625. Date of Electronic Publication: 2024 Jun 17.Publisher: Springer Country of Publication: Netherlands NLM ID: 8508350 Publication Model: Electronic Cited Medium: Internet ISSN: 1573-2959

Record details

Cefixime loaded bare and functionalized halloysite nanocarriers and their biomedical applications.

• Authors : Verma D; International Graduate Program of Nanoscience and Technology, Graduate School, Chulalongkorn University, Bangkok, 10330, Thailand.; Okhawilai M

Subjects: Cefixime*/Cefixime*/Cefixime*/chemistry ; Anti-Bacterial Agents*/Anti-Bacterial Agents*/Anti-Bacterial Agents*/chemistry ; Clay*/Clay*/Clay*/chemistry

• Source: Environmental research [Environ Res] 2024 Jul 01; Vol. 252 (Pt 2), pp. 118927. Date of Electronic Publication: 2024 Apr 15.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 0147621 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Cefixime removal via WO 3 /Co-ZIF nanocomposite using machine learning methods.

• Authors : Sheikhmohammadi A; Department of Environmental Health Engineering, School of Health, Khoy University of Medical Sciences, Khoy, Iran.; Alamgholiloo H

Subjects: Nanocomposites*/Nanocomposites*/Nanocomposites*/chemistry ; Machine Learning* ; Oxides*/Oxides*/Oxides*/chemistry

• Source: Scientific reports [Sci Rep] 2024 Jun 15; Vol. 14 (1), pp. 13840. Date of Electronic Publication: 2024 Jun 15.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Efficacy of empirical Ciprofloxacin or Cefixime plus Metronidazole therapy for the treatment of liver abscess: a randomized control clinical trial.

• Authors : Priya G L; Department of Internal Medicine, Nehru Hospital PGIMER, F-Block, Chandigarh, 160012, India.; Dhibar DP

Subjects: Ciprofloxacin*/Ciprofloxacin*/Ciprofloxacin*/administration & dosage ; Ciprofloxacin*/Ciprofloxacin*/Ciprofloxacin*/therapeutic use ; Metronidazole*/Metronidazole*/Metronidazole*/administration & dosage

• Source: Scientific reports [Sci Rep] 2024 May 20; Vol. 14 (1), pp. 11430. Date of Electronic Publication: 2024 May 20.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Cellulose-based CoFe LDH composite as a nano-adsorbent for sulfamethoxazole and cefixime residues: Evaluation of performance, green metrics and cytotoxicity.

• Authors : Kotp AA; Materials Science and Nanotechnology Department, Faculty of Postgraduate Studies for Advanced Science (PSAS), Beni-Suef University, Beni-Suef 62511, Egypt.; Allam AA

Subjects: Cellulose*/Cellulose*/Cellulose*/chemistry ; Sulfamethoxazole*/Sulfamethoxazole*/Sulfamethoxazole*/chemistry ; Sulfamethoxazole*/Sulfamethoxazole*/Sulfamethoxazole*/toxicity

• Source: Journal of contaminant hydrology [J Contam Hydrol] 2024 May; Vol. 264, pp. 104364. Date of Electronic Publication: 2024 May 10.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 8805644 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

[Modern pharmacotherapy of acute bacterial sinusitis: results of an open randomized clinical trial of the therapeutic equivalence of Cefixime EXPRESS and Suprax Solutab].

• Authors : Kryukov AI; Sverzhevsky Research Clinical Institute of Otorhinolaryngology, Moscow, Russia.; Pirogov Russian National Research Medical University, Moscow, Russia.

Subjects: Cefixime*/Cefixime*/Cefixime*/administration & dosage ; Anti-Bacterial Agents*/Anti-Bacterial Agents*/Anti-Bacterial Agents*/administration & dosage ; Anti-Bacterial Agents*/Anti-Bacterial Agents*/Anti-Bacterial Agents*/therapeutic use

• Source: Vestnik otorinolaringologii [Vestn Otorinolaringol] 2024; Vol. 89 (3), pp. 48-56.Publisher: Media Sfera Country of Publication: Russia (Federation) NLM ID: 0416577 Publication Model: Print Cited Medium: Print ISSN: 0042-4668

Record details

Agricola

Record details

Comparative study of cefixime and tetracycline as an evaluation policy driven by the antibiotic resistance crisis in Indonesia.

• Authors : Ramdhani D; Department of Pharmaceutical Analysis and Medicinal Chemistry, Faculty of Pharmacy, Padjadjaran University, Sumedang, Indonesia. .; Kusuma SAF

Subjects: Drug Resistance, Bacterial*; Anti-Bacterial Agents/Anti-Bacterial Agents/Anti-Bacterial Agents/*toxicity ; Cefixime/Cefixime/Cefixime/*toxicity

• Source: Scientific reports [Sci Rep] 2021 Sep 16; Vol. 11 (1), pp. 18461. Date of Electronic Publication: 2021 Sep 16.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details